Drugs.com - Pharma Industry News

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk

MONDAY, March 3, 2025 -- Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors in...

Mar 3, 2025 - 18:16
 0
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk
MONDAY, March 3, 2025 -- Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors in...
Read More

Tags:

Previous Article

Mortality Increased With Hospital-Based Care for Hallucinogen Use

Next Article

AAN: Marine Microplastic Levels Linked to Cognitive, Other Disabilities

Related Posts

Appropriate Nurse Staffing Tied to Lower Cesarean Birth Rates

Appropriate Nurse Staffing Tied to Lower Cesarean Birth...

Feb 11, 2025  0

Racial, Ethnic Disparities Seen in Counseling for Children With High BP

Racial, Ethnic Disparities Seen in Counseling for Child...

Feb 9, 2025  0

Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer

Talazoparib + Enzalutamide Tied to Improved Overall Sur...

Feb 19, 2025  0